Intraregional model for end-stage liver disease score variation in liver transplantation: Disparity in our own backyard

被引:25
|
作者
Croome, Kristopher P. [1 ]
Lee, David D. [1 ]
Burns, Justin M. [1 ]
Keaveny, Andrew P. [1 ]
Taner, C. Burcin [1 ]
机构
[1] Mayo Clin Florida, Dept Transplant, 4500 San Pablo Rd, Jacksonville, FL 32224 USA
关键词
D O I
10.1002/lt.25021
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Variation in average Model for End-Stage Liver Disease (MELD) score at liver transplantation (LT) by United Network for Organ Sharing (UNOS) regions is well documented. The present study aimed to investigate MELD variation at the interregional, intraregional, and intra-donation service area (DSA) levels. Patients undergoing LT between 2015 and 2016 were obtained from the UNOS standard analysis and research file. The distribution of allocation MELD score including median, skew, and kurtosis was examined for all transplant programs. Intraregional median allocation MELD varied significantly within all 11 UNOS regions. The largest variation between programs was seen in region 5 (MELD 24.0 versus 38.5) and region 3 (MELD 20.5 versus 32.0). Regions 1, 5, and 9 had the largest proportion of programs with a highly negative skewed MELD score (50%, 57%, and 57%, respectively), whereas regions 3, 6, 10, and 11 did not have any programs with a highly negative skew. MELD score distribution was also examined in programs located in the same DSA, where no barriers exist and theoretically no significant difference in allocation should be observed. The largest DSA variation in median allocation MELD score was seen in NYRT-OP1 LiveOnNY (MELD score variation 11), AZOB-OP1 Donor Network of Arizona (MELD score variation 11), MAOB-OP1 New England Organ Bank (MELD score variation 9), and TXGC-OP1 LifeGift Organ Donation Ctr (MELD score variation 9). In conclusion, the present study demonstrates that this MELD disparity is not only present at the interregional level but can be seen within regions and even within DSAs between programs located as close as several city blocks away. Although organ availability likely accounts for a component of this disparity, the present study suggests that transplant center behavior may also play a significant role. Liver Transplantation 24 488-496 2018 AASLD.
引用
收藏
页码:488 / 496
页数:9
相关论文
共 50 条
  • [1] Liver Transplantation in Recipients With High Model for End-stage Liver Disease Score
    Gonzalez Martinez, S.
    Molina Raya, A.
    Becerra Massare, A.
    Muffak Granero, K.
    Villegas Herrera, T.
    Villar del Moral, J. M.
    Fundora Suarez, Y.
    TRANSPLANTATION PROCEEDINGS, 2018, 50 (02) : 595 - 597
  • [2] Mind the Model for End-Stage Liver Disease: Model for End-Stage Liver Disease Score as an Indicator of Hemoderivate Transfusion and Survival in Liver Transplantation
    Alonso, I. J.
    Maestro, O. C.
    Gomez, N. F.
    Mateos, R. S.
    Quinto, A. M.
    Molero, F. C.
    Municio, A. M.
    Pulido, J. C.
    Segurola, C. L.
    Romero, C. J.
    TRANSPLANTATION PROCEEDINGS, 2015, 47 (01) : 97 - 99
  • [3] Could tenofovir modify the model end-stage liver disease (MELD) score in patients with end-stage liver disease eligible for liver transplantation?
    Bruno, Raffaele
    Sacchi, Paolo
    Filice, Gaetano
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2007, 45 (01) : 123 - 123
  • [4] Impact of Model for End-Stage Liver Disease Score on Transfusion Rates in Liver Transplantation
    Varotti, G.
    Santori, G.
    Andorno, E.
    Morelli, N.
    Erteo, M.
    Strada, P.
    Porcile, E.
    Casaccia, M.
    Centanaro, M.
    Valente, U.
    TRANSPLANTATION PROCEEDINGS, 2013, 45 (07) : 2684 - 2688
  • [5] Model for end-stage liver disease score predicts complications after liver transplantation
    Pommergaard, Hans-Christian
    Daugaard, Thomas Rojkjaer
    Rostved, Andreas Arendtsen
    Schultz, Nicolai Aagaard
    Hillingso, Jens
    Krohn, Paul Suno
    Rasmussen, Allan
    LANGENBECKS ARCHIVES OF SURGERY, 2021, 406 (01) : 55 - 65
  • [6] Impact of the Model for End-Stage Liver Disease (MELD) Score on Liver Transplantation in Greece
    Karapanagiotou, A.
    Kydona, C.
    Dimitriadis, C.
    Papadopoulos, S.
    Theodoridou, T.
    Tholioti, T.
    Fouzas, G.
    Imvrios, G.
    Gritsi-Gerogianni, N.
    TRANSPLANTATION PROCEEDINGS, 2014, 46 (09) : 3212 - 3215
  • [7] Model for end-stage liver disease score predicts complications after liver transplantation
    Hans-Christian Pommergaard
    Thomas Røjkjær Daugaard
    Andreas Arendtsen Rostved
    Nicolai Aagaard Schultz
    Jens Hillingsø
    Paul Suno Krohn
    Allan Rasmussen
    Langenbeck's Archives of Surgery, 2021, 406 : 55 - 65
  • [8] Living donor liver transplantation in high model for end-stage liver disease score
    Dayangac, Murat
    Akyildiz, Murat
    Erdogan, Yalcin
    Gungor, Gokhan
    Tokat, Yaman
    HEPATOLOGY, 2014, 60 : 509A - 510A
  • [9] THE IMPACT OF LISTING MODEL FOR END-STAGE LIVER DISEASE (MELD) SCORE ON LIVER TRANSPLANTATION
    Fox, Alyson N.
    Reddy, Rajender
    Guttenberg, Katie B.
    Forde, Kimberly A.
    Ellenberg, Susan
    Lewis, James D.
    HEPATOLOGY, 2010, 52 (04) : 664A - 664A
  • [10] LIVING DONOR LIVER TRANSPLANTATION IN HIGH MODEL FOR END-STAGE LIVER DISEASE SCORE
    Dayangac, M.
    Akyildiz, M.
    Gungor, G.
    Erdogan, Y.
    Tokat, Y.
    TRANSPLANT INTERNATIONAL, 2014, 27 : 22 - 23